… that are associated with the Ontology of Adverse Events. … to use the term ‘adverse event’ to
represent individual cases, … from OntoSPM was used to set a relation between a measurement …

… Ontology-based collection, representation and analysis of drug-associated neuropathy adverse
events. J Biomed … ODAE: Ontology-based systematic representation and analysis of drug …

… create and analyze an ontology knowledge base of drug-associated neuropathy adverse
effects. … , J., Jiang, G., Zhu, Q., He, Y., Ontology-based collection, representation and analysis of …

… A 479 pitfall of our ontology-based study is that not all the drugs have … Ontology-based
collection, representation and analysis of drug-associated 768 neuropathy adverse events. J …

… domain have been used to represent the relationships and syntactic various are … -set also
produced a good predictive result. In this work, they used twelve seeds in to the one data-set …

… for causal ontology-based drug repurposing. Thus, in this … the presence or absence of
adverse effects. Taking advantage of … classifier involved gathering drug-associated data (features) …

… , which is different from our drug collection based on drug-virus … our ontology-based
representation and analysis in the future. … of drug-associated neuropathy adverse events. J …

… for causal ontology-based drug repurposing. Thus, in this … the presence or absence of
adverse effects. Taking advantage of … classifier involved gathering drug associated data (features) …

… Higher layers of HLGT and SOC represent biologically and … In an un-enriched AE group,
we either set the range of p0 … As shown in Table 4, AEKS identified Peripheral neuropathies, …

… neuropathy when DIN is stopped. This review synthesizes current clinical concepts regarding
mechanisms, drug-induced neuropathy, and treatment options for drug-induced peripheral …